202 related articles for article (PubMed ID: 28972958)
21. STAT3, STAT5A, STAT5B and STAT6 proteins are overexpressed in human basal cell carcinoma.
Sławińska M; Lakomy J; Biernat W; Sokołowska-Wojdyło M; Karczewska J; Zabłotna M; Jankau J; Nowicki RJ; Sobjanek M
Clin Exp Dermatol; 2020 Mar; 45(2):165-171. PubMed ID: 31323143
[TBL] [Abstract][Full Text] [Related]
22. N-terminal truncation of Stat5a/b circumvents PIAS3-mediated transcriptional inhibition of Stat5 in prostate cancer cells.
Dagvadorj A; Tan SH; Liao Z; Xie J; Nurmi M; Alanen K; Rui H; Mirtti T; Nevalainen MT
Int J Biochem Cell Biol; 2010 Dec; 42(12):2037-46. PubMed ID: 20854925
[TBL] [Abstract][Full Text] [Related]
23. Phosphorylation of signal transducer and activator of transcription 3 in soft tissue leiomyosarcoma is associated with a better prognosis.
Setsu N; Kohashi K; Endo M; Yamamoto H; Tamiya S; Takahashi Y; Yamada Y; Ishii T; Matsuda S; Yokoyama R; Iwamoto Y; Oda Y
Int J Cancer; 2013 Jan; 132(1):109-15. PubMed ID: 22644781
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of PIAS3 suppresses cell growth and restores the drug sensitivity of human lung cancer cells in association with PI3-K/Akt inactivation.
Ogata Y; Osaki T; Naka T; Iwahori K; Furukawa M; Nagatomo I; Kijima T; Kumagai T; Yoshida M; Tachibana I; Kawase I
Neoplasia; 2006 Oct; 8(10):817-25. PubMed ID: 17032498
[TBL] [Abstract][Full Text] [Related]
25. Low PIAS3 expression in malignant mesothelioma is associated with increased STAT3 activation and poor patient survival.
Dabir S; Kluge A; Kresak A; Yang M; Fu P; Groner B; Wildey G; Dowlati A
Clin Cancer Res; 2014 Oct; 20(19):5124-32. PubMed ID: 25124686
[TBL] [Abstract][Full Text] [Related]
26. Unphosphorylated STAT6 contributes to constitutive cyclooxygenase-2 expression in human non-small cell lung cancer.
Cui X; Zhang L; Luo J; Rajasekaran A; Hazra S; Cacalano N; Dubinett SM
Oncogene; 2007 Jun; 26(29):4253-60. PubMed ID: 17237818
[TBL] [Abstract][Full Text] [Related]
27. Activated epidermal growth factor receptor-Stat-3 signaling promotes tumor survival in vivo in non-small cell lung cancer.
Haura EB; Zheng Z; Song L; Cantor A; Bepler G
Clin Cancer Res; 2005 Dec; 11(23):8288-94. PubMed ID: 16322287
[TBL] [Abstract][Full Text] [Related]
28. STATs in Lung Development: Distinct Early and Late Expression, Growth Modulation and Signaling Dysregulation in Congenital Diaphragmatic Hernia.
Piairo P; Moura RS; Baptista MJ; Correia-Pinto J; Nogueira-Silva C
Cell Physiol Biochem; 2018; 45(1):1-14. PubMed ID: 29310117
[TBL] [Abstract][Full Text] [Related]
29. Expressional STAT3/STAT5 Ratio is an Independent Prognostic Marker in Colon Carcinoma.
Klupp F; Diers J; Kahlert C; Neumann L; Halama N; Franz C; Schmidt T; Lasitschka F; Warth A; Weitz J; Koch M; Schneider M; Ulrich A
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1548-55. PubMed ID: 25773877
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-18a modulates STAT3 activity through negative regulation of PIAS3 during gastric adenocarcinogenesis.
Wu W; Takanashi M; Borjigin N; Ohno SI; Fujita K; Hoshino S; Osaka Y; Tsuchida A; Kuroda M
Br J Cancer; 2013 Feb; 108(3):653-61. PubMed ID: 23322197
[TBL] [Abstract][Full Text] [Related]
31. Activation state EGFR and STAT-3 as prognostic markers in resected non-small cell lung cancer.
Cortas T; Eisenberg R; Fu P; Kern J; Patrick L; Dowlati A
Lung Cancer; 2007 Mar; 55(3):349-55. PubMed ID: 17161498
[TBL] [Abstract][Full Text] [Related]
32. Activity of the suppressor of cytokine signaling-3 promoter in human non-small-cell lung cancer.
He B; You L; Xu Z; Mazieres J; Lee AY; Jablons DM
Clin Lung Cancer; 2004 May; 5(6):366-70. PubMed ID: 15217536
[TBL] [Abstract][Full Text] [Related]
33. STAT-5 is activated constitutively in T cells, B cells and monocytes from patients with primary Sjögren's syndrome.
Pertovaara M; Silvennoinen O; Isomäki P
Clin Exp Immunol; 2015 Jul; 181(1):29-38. PubMed ID: 25736842
[TBL] [Abstract][Full Text] [Related]
34. [Expression and clinical significance of COX-2, p-Stat3, and p-Stat5 in esophageal carcinoma].
Liu JR; Wang Y; Zuo LF; Li FL; Wang Y; Liu JL
Ai Zheng; 2007 May; 26(5):458-62. PubMed ID: 17672932
[TBL] [Abstract][Full Text] [Related]
35. Suppressor of cytokine signalling-2 limits IGF1R-mediated regulation of epithelial-mesenchymal transition in lung adenocarcinoma.
Zhou Y; Zhang Z; Wang N; Chen J; Zhang X; Guo M; John Zhong L; Wang Q
Cell Death Dis; 2018 Apr; 9(4):429. PubMed ID: 29559623
[TBL] [Abstract][Full Text] [Related]
36. The transcriptional STAT3 is a potential target, whereas transcriptional STAT5A/5B/6 are new biomarkers for prognosis in human breast carcinoma.
Wu HT; Liu J; Li GW; Shen JX; Huang YT
Oncotarget; 2017 May; 8(22):36279-36288. PubMed ID: 28422733
[TBL] [Abstract][Full Text] [Related]
37. Histone deacetylases inhibitor sodium butyrate inhibits JAK2/STAT signaling through upregulation of SOCS1 and SOCS3 mediated by HDAC8 inhibition in myeloproliferative neoplasms.
Gao SM; Chen CQ; Wang LY; Hong LL; Wu JB; Dong PH; Yu FJ
Exp Hematol; 2013 Mar; 41(3):261-70.e4. PubMed ID: 23111066
[TBL] [Abstract][Full Text] [Related]
38. [The expressions of STAT3, WWOX and c-myc in human non small cell lung cancer tissue and correlativity analysis].
Hu FY; Wang LP; Hou LL; Yin G; Wang HC
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Dec; 26(12):1203-5, 1209. PubMed ID: 21138684
[TBL] [Abstract][Full Text] [Related]
39. FHIT promoter methylation status, low protein and high mRNA levels in patients with non-small cell lung cancer.
Czarnecka KH; Migdalska-Sęk M; Domańska D; Pastuszak-Lewandoska D; Dutkowska A; Kordiak J; Nawrot E; Kiszałkiewicz J; Antczak A; Brzeziańska-Lasota E
Int J Oncol; 2016 Sep; 49(3):1175-84. PubMed ID: 27572663
[TBL] [Abstract][Full Text] [Related]
40. The transcriptional responsiveness of LKB1 to STAT-mediated signaling is differentially modulated by prolactin in human breast cancer cells.
Linher-Melville K; Singh G
BMC Cancer; 2014 Jun; 14():415. PubMed ID: 24913037
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]